Question 1

What does peer-reviewed research say about these claims?

Accepted Answer

Bro translation: Mainstream medical consensus does not support the claim that a 'sluggish liver' is a primary cause or closely associated driver of hypothyroidism; hypothyroidism is overwhelmingly caused by autoimmune destruction (Hashimoto's), iodine deficiency, or medication side effects, not liver detoxification capacity. Furthermore, the concept of 'sub-optimal' liver function that evades standard blood tests (AST, ALT, bilirubin) is not supported by evidence; standard liver function tests are highly sensitive for detecting actual liver pathology, and the 'sub-optimal' diagnosis is a functional medicine construct used to justify unproven testing and supplements.

Question 2

Are Jaban M Moore's credentials legitimate?

Accepted Answer

Jaban Moore presents as a chiropractor, a real state-regulated credential with a narrower musculoskeletal and nervous-system scope. The site nevertheless markets broad disease-cause assessment and systemic detoxification concepts, creating credential inflation through specialty overreach. Stated credentials: none detected. Likely credentials: Chiropractor (DC), DC. Credential inflation detected, a white coat is not the same as an MD/DO license.

Question 3

Is Dr Jaban M Moore a real medical doctor?

Accepted Answer

Jaban M Moore is not identified as an MD/DO physician in reviewed credentials or public registry data. Likely credential: Chiropractor (DC).

Question 4

Does Jaban M Moore use Fear Mongering?

Accepted Answer

Invents a hidden disease state ('sub-optimal') that standard medical tests miss, creating anxiety to sell unproven liver support protocols. Likely motive: Drive traffic to 'virtual clinic' for paid consultations and supplement sales.

Question 5

Does Jaban M Moore use False Authority?

Accepted Answer

Uses 'our experience' (anecdotal) to claim a causal link between a vague functional concept ('sluggish liver') and a serious autoimmune/endocrine disease (hypothyroidism), bypassing peer-reviewed evidence. Likely motive: Position the clinic as the sole expert on 'root cause' thyroid issues.

Question 6

Is the claim "Your doctor may have told you your liver function is fine, but it can still be operatin…" supported by medical literature?

Accepted Answer

There is substantial high-quality evidence that normal standard liver function tests do not reliably rule out chronic or even advanced liver disease, which directly supports the idea that the liver can be subclinically or silently impaired despite “normal” lab results. StatPearls’ liver function tests chapter, written in guideline style and regularly updated, states that normal liver panels do not exclude clinically meaningful liver disease, fibrosis, or compensated chronic liver disease, particularly in metabolic-associated steatotic liver disease (MASLD/NAFLD). It emphasizes that normal values are best understood as “biochemically quiet” rather than disease-free, indicating the possibility of suboptimal liver status despite reassuring tests.[11] A 2018 peer‑reviewed review explicitly titled around the misconception that you cannot have liver disease with normal aminotransferases concludes that many patients with chronic liver disease and progressive fibrosis have normal ALT, and even cirrhosis can be present when ALT is within standard reference ranges; therefore, liver chemistries cannot be used as absolute markers to detect or exclude liver disease.[12] A 2025 study on defining normal liver function tests reports that a substantial proportion of cirrhotic patients had normal LFTs, underscoring that normal enzyme levels do not exclude advanced liver disease.[7] Clinical reviews and guidance documents for primary care likewise state that severe liver disease may be present with little or no liver function abnormality and that normal or minimally abnormal liver biochemical tests do not preclude significant liver disease, even cirrhosis.[3][4][15] In NAFLD/MASLD, major clinical guidance from academic centers and family practice reviews note that liver enzymes are often normal, and routine screening based on enzymes alone is not recommended, because steatosis and fibrosis can exist despite normal ALT and AST.[6][8][9][11][14] Together, these guideline-like and review sources support the general claim that a patient can be told their liver function is fine based on routine tests while the liver is still operating less than optimally at a pathological level (e.g., fatty infiltration, fibrosis, compensated cirrhosis) that standard panels fail to detect. The main tension with the influencer’s phrasing is that mainstream evidence talks about “subclinical or compensated chronic liver disease” rather than a vaguely defined “sub‑optimal” liver, and it cautions against over‑interpreting normal tests as either perfectly healthy or meaningfully impaired. StatPearls emphasizes that a normal liver panel indicates the absence of strong biochemical signals of injury or synthetic failure at the time of testing, and many mild or isolated abnormalities are transient or clinically insignificant.[11] This implies that, for many people with normal liver tests and no other risk factors or symptoms, there is no evidence that their liver is functionally impaired in a way that matters clinically. Routine guidance documents for interpreting liver function tests stress that results must be interpreted in clinical context and that normal values, in an otherwise low‑risk individual, are generally reassuring rather than a sign of hidden dysfunction requiring treatment.[3][4][15] No major systematic reviews or guidelines support broad assertions that large numbers of people with normal tests have a liver that is “operating sub‑optimally” in a non‑pathologic wellness sense (e.g., vague fatigue, detox claims); the evidence focuses on specific, diagnosable entities (NAFLD, fibrosis, compensated cirrhosis) and on test limitations, not on generalized underperformance of the liver. The available literature does not support using the concept of suboptimal liver function as a blanket explanation for nonspecific symptoms in people whose clinical evaluation is otherwise normal, nor does it support the idea that normal lab reports from a doctor are commonly missing clinically important dysfunction in average‑risk patients. Instead, it underscores that normal tests do not absolutely exclude disease but also should not be over‑interpreted as evidence of disease without additional risk factors, imaging, or biopsy findings.[11][12][13] Mainstream hepatology and general medical practice hold that standard liver function tests (ALT, AST, ALP, GGT, bilirubin, albumin, INR) are useful screening tools but have important limitations: normal results reduce the likelihood of significant acute injury or decompensated disease, yet they do not definitively exclude chronic or compensated liver disease such as NAFLD/MASLD or early fibrosis.[11][12][3][4][13] Guidelines and expert reviews recommend that clinicians interpret liver tests in the broader clinical context—risk factors (obesity, alcohol, viral hepatitis, medications), symptoms, imaging, and sometimes non‑invasive fibrosis scores or biopsy—rather than Literature verdict: mixed.

Question 7

Is the claim "Hormones out of whack likely means liver function is not so great" supported by medical literature?

Accepted Answer

There is substantial evidence that chronic liver disease and cirrhosis are associated with multiple hormone abnormalities, including altered sex hormones, thyroid hormones, cortisol, insulin and growth hormone. Reviews and cohort studies show that cirrhosis is associated with elevated estrogens, reduced testosterone, hypogonadism, thyroid dysfunction, adrenal insufficiency and other endocrine changes.[1][3][4][5][7][9][10][11][12][13][15][16][23] These data support that when liver function is significantly impaired (e.g., advanced cirrhosis or severe chronic liver disease), hormone levels are often “out of whack” and that impaired hepatic metabolism and clearance contribute causally to these abnormalities.[3][5][7][9][11][13][16][23] The available evidence does not support the broad claim that any or most cases of “hormones out of whack” are likely due to poor liver function. Many endocrine disorders (primary thyroid disease, ovarian and testicular disorders, pituitary disease, polycystic ovary syndrome, obesity-related insulin resistance, etc.) occur with normal liver function and are driven by primary endocrine pathology rather than hepatic dysfunction.[5][13][16][17][18][19][21][22][24] The relationship between liver and hormones is bidirectional: endocrine diseases such as Cushing’s syndrome, hypothyroidism, hyperthyroidism, diabetes and sex-steroid excess can themselves induce or worsen liver disease; in these situations, hormones are abnormal first and liver dysfunction develops second, contradicting a simple one-way causal claim that hormone imbalance mainly reflects poor liver function.[5][13][16][17][18][20][22][23] Moreover, many people with early or mild liver disease have relatively preserved hormonal profiles, and major guidelines for hypertension, nutrition support, IBD and other conditions do not treat unexplained hormone abnormalities as a reliable proxy for impaired liver function, reflecting that the evidence is too heterogeneous and non-specific.[0][1][2][4][6] Mainstream hepatology and endocrinology recognize a close, bidirectional relationship between liver function and endocrine systems: the liver is an important metabolic and endocrine organ, and advanced liver disease commonly causes multiple hormone disturbances, while primary endocrine disorders can also cause or aggravate liver disease.[3][5][7][9][13][15][16][17][23] However, the prevailing medical view is that hormone imbalance is a non-specific finding with many possible etiologies, and cannot by itself be taken to mean that liver function is “not so great”; appropriate evaluation includes direct assessment of liver (e.g., liver enzymes, imaging, fibrosis assessment) and endocrine organs (e.g., thyroid, gonads, pituitary, adrenal), rather than assuming liver dysfunction is the primary cause.[3][5][13][16][23] Clinically, significant hormone abnormalities may prompt consideration of liver disease as one of several differential diagnoses, especially in suspected cirrhosis or MASLD, but routine practice does not treat hormone imbalance alone as a reliable indicator that liver function is impaired.[9][10][11][12][17][18][23] Literature verdict: mixed.

Question 8

Is the claim "A sluggish liver is closely associated with hypothyroidism" supported by medical literature?

Accepted Answer

High-quality evidence shows that thyroid function and liver function are biologically interconnected, and hypothyroidism is associated with a higher prevalence of fatty liver and some liver-related events, but this is described as an association, not as a simple “sluggish liver” being closely linked to hypothyroidism. Recent reviews of the thyroid–liver axis state that the liver requires adequate thyroid hormone to execute metabolic functions optimally and that thyroid hormone deficiency can lead to liver dysfunction, including abnormalities in lipid metabolism and non-alcoholic fatty liver disease (NAFLD). These reviews conclude that hepatic dysfunction associated with hypothyroidism usually improves when thyroid status is normalized, supporting a bidirectional thyroid–liver axis.[19] Multiple systematic reviews and meta-analyses report that overt and subclinical hypothyroidism are associated with increased odds of NAFLD or metabolic dysfunction–associated steatotic liver disease (MASLD); pooled odds ratios are typically in the 1.4–2.0 range, suggesting a modest but consistent association between hypothyroidism and steatotic liver disease.[4][5][13][14][16][15][17] Observational data also show that higher thyroid-stimulating hormone (TSH) levels, even in subclinical hypothyroidism, correlate with more severe steatosis and higher risk of MASLD or steatohepatitis in some cohorts, supporting a link between hypothyroid status and certain liver abnormalities.[12][16][20][22] In patients with pre-existing chronic liver disease, subclinical and overt hypothyroidism have been associated with increased risk of liver-related events in a dose-dependent fashion, suggesting that hypothyroidism can worsen liver outcomes in susceptible patients.[9] The influencer’s wording that a “sluggish liver is closely associated with hypothyroidism” is not directly supported by high-quality evidence; the literature describes a complex, bidirectional relationship between thyroid dysfunction and specific liver diseases rather than a broad concept of sluggish liver. Reviews emphasize that while hypothyroidism and NAFLD/MASLD frequently coexist, their interdependence is not a straightforward cause-and-effect relationship, and metabolic factors such as obesity, insulin resistance, and dyslipidemia remain dominant drivers of fatty liver.[11][8][23] Some systematic reviews and meta-analyses have found no significant association between NAFLD and hypothyroidism or thyroid hormone levels, indicating that not all data support a strong or consistent link.[3][7][11] Even in meta-analyses showing increased prevalence of NAFLD/MASLD in hypothyroidism, the evidence is largely observational, cross-sectional, and prone to confounding, so it cannot establish that hypothyroidism causes liver to become “sluggish” nor that liver sluggishness causes hypothyroidism.[4][5][13][14][16][15][17] Studies of fibrosis risk in MASLD suggest that subclinical hypothyroidism is not independently associated with advanced fibrosis once age and metabolic factors are accounted for, which weakens the claim that thyroid dysfunction and overall liver impairment are closely linked in a causal sense.[23][21] Traditional clinical reviews of thyroid–liver relationships mainly describe mild elevations in liver enzymes and reversible metabolic changes, not a distinct clinical entity of “sluggish liver” strongly tied to hypothyroidism.[10][19] Mainstream endocrinology and hepatology recognize a thyroid–liver axis in which thyroid hormones influence hepatic lipid and glucose metabolism, bile acid homeostasis, and liver enzyme patterns, and hypothyroidism can be associated with abnormal liver tests and increased risk of NAFLD/MASLD.[19][8][10] However, the prevailing view is that hypothyroidism is one of several metabolic risk factors for steatotic liver disease and liver-related events, and its effects are generally modest and mediated through changes in lipids, weight, and insulin resistance rather than a simple concept of the liver becoming globally “sluggish.”[4][5][13][14][16][15][17][11] Major reviews and meta-analyses characterize the relationship as associative and bidirectional, emphasize heterogeneity in study findings, and highlight that correcting hypothyroidism can improve some liver abnormalities, but they do not endorse the notion of a distinct, commonly accepted syndrome of sluggish liver closely associated with hypothyroidism.[11][19][10] Current guidelines and expert reviews focus on screening for NAFLD/MASLD in patients with metabolic risk factors (including hypothyroidism) and on managing hypothyroidism according to standard criteria; they do not describe or treat “sluggish liver” as a recognized Literature verdict: mixed.

Advertised	Verdict
Your doctor may have told you your liver function is fine, but it can still be operating sub-optimally Rule: RSMo 331.010.1 Assessing whether the liver is functioning sub-optimally is a systemic-organ medical assessment rather than diagnosis of a malpositioned articulation or bodily structure directed to neuromusculoskeletal or musculoskeletal function.	Outside scope
Diagnosing hypothyroidism via 'sluggish liver' Rule: RSMo 331.010.1 Diagnosing hypothyroidism through an alleged liver condition is diagnosis of systemic endocrine and organ disease, which the Missouri chiropractic statute does not affirmatively authorize and expressly distinguishes from the practice of medicine.	Outside scope

Jaban M Moore alias Dr. Sub-Optimal Liver

Score breakdown

Key findings

Claims & evidence

Manipulation

Borrowed authority & guest funnel

Host self-funnel

Commerce & grift map

Credentials & scope

Permitted scope vs advertised

What this license permits

Validated associated properties

Analyzed

Funnel routes (third-party)

Tip the jar

Fight disinformation

Log a new mention

Reply snippets

Recent mentions (this doc)

Nudge the Doc Bro

Pick a contact address

What gets sent

Know someone who can help?

Who should we nudge?

What gets sent

Whambulance

Public challenge log

File a challenge

Citations